Literature DB >> 15195509

Effects of heat shock on the Mre11/Rad50/Nbs1 complex in irradiated or unirradiated cells.

J R Dynlacht1, M Xu, R K Pandita, E A Wetzel, J L Roti Roti.   

Abstract

The mechanism by which hyperthermia sensitizes mammalian cells to ionizing radiation remains to be elucidated, but an overwhelming amount of circumstantial evidence suggests that heat radiosensitization might be mediated by inhibition of double-strand break repair, particularly after exposure of irradiated cells to heat treatments in excess of about 43 degrees C. In mammalian cells, double-strand break repair usually occurs via two pathways, non-homologous end-joining and homologous recombination. Several reports suggest a role for non-homologous end-joining in heat radiosensitization, while others implicate homologous recombination as a target. However, cell lines that are compromised in either the non-homologous end-joining or homologous recombination pathway are still capable of being radiosensitized, suggesting that heat affects both pathways. Indeed, several of the proteins involved in one or both of these pathways have been observed to undergo alterations or translocation after unirradiated or irradiated cells are exposed to heat shock. The work summarized in this review implicates proteins of the Mre11/Rad50/Nbs1 complex as targets for heat radiosensitization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195509     DOI: 10.1080/02656730410001660634

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  2 in total

1.  Hyperthermia alters the interaction of proteins of the Mre11 complex in irradiated cells.

Authors:  Bogdan I Gerashchenko; Gerirose Gooding; Joseph R Dynlacht
Journal:  Cytometry A       Date:  2010-08-18       Impact factor: 4.355

2.  Identification of Mre11 as a target for heat radiosensitization.

Authors:  Joseph R Dynlacht; Christopher N Batuello; Jennifer T Lopez; Kyung Keun Kim; John J Turchi
Journal:  Radiat Res       Date:  2011-06-23       Impact factor: 2.841

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.